Author: Yong-an Ye
Title: Guideline-based Chinese herbal medicine treatment plus standard care for severe coronavirus disease 2019 (G-CHAMPS): evidence from China Document date: 2020_4_1
ID: 4as055wh_1
Snippet: Approximately 14-16% patients with Coronavirus disease 2019 (COVID-19) suffer from severe diseases like pneumonia and 5% become critically ill (1, 2) . The mortality rate of COVID-19 among those suffering critical illness was reported to be over 50% (1) .The National Health Commission and the National Administration of Traditional Chinese Medicine of the People's Republic of China developed clinical guidelines for the management of COVID-19 (NHC-.....
Document: Approximately 14-16% patients with Coronavirus disease 2019 (COVID-19) suffer from severe diseases like pneumonia and 5% become critically ill (1, 2) . The mortality rate of COVID-19 among those suffering critical illness was reported to be over 50% (1) .The National Health Commission and the National Administration of Traditional Chinese Medicine of the People's Republic of China developed clinical guidelines for the management of COVID-19 (NHC-NATCM-China guidelines) (3, 4) . In these guidelines, CHM was included as part of the treatment plans for severe COVID-19. These recommendations were developed by the consensus of experts. We thus conducted this pilot randomized clinical trial (RCT) to test the potential effectiveness of the guideline-based CHM treatment for severe COVID-19 in Wuhan, China.
Search related documents:
Co phrase search for related documents- chm treatment and Coronavirus disease: 1, 2, 3, 4, 5, 6, 7, 8, 9
- chm treatment and critical illness: 1, 2
- chm treatment and mortality rate: 1
- chm treatment and NHC NATCM China guideline: 1
- clinical guideline and Coronavirus disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical guideline and expert consensus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- clinical guideline and mortality rate: 1, 2, 3, 4
- clinical trial and Coronavirus disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical trial and critical illness: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- clinical trial and expert consensus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- clinical trial and expert consensus develop: 1, 2
- clinical trial and mortality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical trial and pilot randomize: 1
- clinical trial and potential effectiveness: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- Coronavirus disease and critical illness: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- Coronavirus disease and critical illness suffer: 1, 2
- Coronavirus disease and expert consensus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- Coronavirus disease and expert consensus develop: 1, 2
- Coronavirus disease and guideline base: 1
Co phrase search for related documents, hyperlinks ordered by date